
Sign up to save your podcasts
Or


Interview with Jennifer A. Pietenpol, PhD, Brian D. Lehmann, PhD, and Vandana G. Abramson, MD, authors of Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial. Hosted by Mary L. (Nora) Disis, MD.
Related Content:
By The JAMA Network4.9
1212 ratings
Interview with Jennifer A. Pietenpol, PhD, Brian D. Lehmann, PhD, and Vandana G. Abramson, MD, authors of Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial. Hosted by Mary L. (Nora) Disis, MD.
Related Content:

136 Listeners

320 Listeners

697 Listeners

497 Listeners

36 Listeners

103 Listeners

291 Listeners

3,349 Listeners

38 Listeners

13 Listeners

16 Listeners

19 Listeners

7 Listeners

1,146 Listeners

29 Listeners

193 Listeners

92 Listeners

515 Listeners

368 Listeners

426 Listeners

18 Listeners

374 Listeners

61 Listeners